ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08575
0,00%
Bitcoin
67.656,15
0,26%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. 180 Life Sciences Corporation (ATNF)

  7. 180 Life Sciences Corporation (ATNF) News

ATNF

180 Life Sciences (ATNF)

180 Life Sciences Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ATNF
DatumZeitQuelleÜberschriftSymbolFirma
14/03/202413h30GlobeNewswire Inc.180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:ATNF180 Life Sciences Corporation
11/03/202412h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
08/03/202422h49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
29/02/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
28/02/202412h42Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
28/02/202412h39Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
28/02/202412h37Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
28/02/202412h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
26/02/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
26/02/202413h00GlobeNewswire Inc.180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance PlanNASDAQ:ATNF180 Life Sciences Corporation
20/02/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
16/02/202423h10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
16/02/202423h08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
16/02/202423h05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
16/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
12/02/202422h15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATNF180 Life Sciences Corporation
31/01/202423h29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ATNF180 Life Sciences Corporation
29/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
17/01/202414h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
16/01/202414h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
29/12/202300h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATNF180 Life Sciences Corporation
27/12/202322h15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATNF180 Life Sciences Corporation
26/12/202322h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATNF180 Life Sciences Corporation
21/12/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
20/12/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
18/12/202322h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATNF180 Life Sciences Corporation
15/12/202314h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
14/12/202322h30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ATNF180 Life Sciences Corporation
04/12/202315h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATNF180 Life Sciences Corporation
04/12/202315h00GlobeNewswire Inc.180 Life Sciences Engages Financial Advisor to Explore Strategic AlternativesNASDAQ:ATNF180 Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:ATNF

Kürzlich von Ihnen besucht

COIN
HERCETH
Hercules
LSE
JRDE
Jpm Eu Rei Dist
EU
HLTW
Amundi MSCI World Health...
LSE
41DQ
Abu Dhabi 30 A
COIN
PEEPOOUSD
PEEPO
ASX
VAS
Vanguard Australian Shar...
TG
AS7
Anta Sports Products
COIN
PEFIUST
Penguin Finance
COIN
OKUST
OKcash
COIN
OXRCUST
OmniXRC
NYSE
RMPL.PR
Rivernorth Marketplace Lending
TG
45U0
Orchid Island Capital
TG
JAL
Japan AIrlines
NASDAQI
FIRSTNORTHSEK
First North All Share SEK
BIT
Q00461
Leonteq Securities
TSXV
SWC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten